A combination of pertuzimab and Enhertu can slow disease progression and improve survival in people with HER2-positive ...

Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

The National Institutes of Health (NIH) is following in the FDA’s footsteps—away from animal testing.  | The National ...

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...

The antibody is to treat adult recurrent or metastatic non-keratinising nasopharyngeal carcinoma (NPC) in conjunction with ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced ...

Not letting its expansion efforts idle, contract manufacturer PCI Pharma Services is picking up a 100% stake in Ajinomoto's ...

Following the suspension of trade with India, Pakistan's health authorities are scrambling to secure pharmaceutical supplies ...

Pakistani health authorities have initiated "emergency preparedness" measures to secure pharmaceutical supplies in response ...

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

The Cancer Biologics Market is witnessing remarkable growth fueled by an expanding therapeutic landscape and a burgeoning pipeline of innovative biologic therapies. Unlike traditional treatments, ...